Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Christopher A. KroegerFounder, President, CEO & Director | -118,24k | 3,21M | Automatic Disposition | 27,19 - 28,15 | 114,12k | -50,89% |
| 2026-05-07 | Dr. James Woodruff LillieChief Scientific Officer | -721,00 | 20,39k | Automatic Disposition | 28,28 | 242,73k | -0,30% |
| 2026-05-07 | Dr. Erin Pennock FoffChief Medical Officer | -4,44k | 126,64k | Automatic Disposition | 28,52 - 29,10 | 346,06k | -1,27% |
| 2026-05-07 | Dr. Christopher A. KroegerFounder, President, CEO & Director | -68,49k | 1,95M | Automatic Disposition | 27,48 - 30,56 | 1,61M | -4,07% |
| 2026-05-11 | Mr. Kristopher L. HansonGeneral Counsel & Secretary | -13,92k | 419,26k | Automatic Disposition | 27,61 - 30,56 | 162,33k | -7,90% |
| 2026-05-04 | Mr. Kristopher L. HansonGeneral Counsel & Secretary | -13,92k | 388,18k | Automatic Disposition | 27,50 - 30,08 | 13,87k | -50,09% |
| 2026-05-04 | Dr. Christopher A. KroegerFounder, President, CEO & Director | -49,74k | 1,41M | Automatic Disposition | 27,50 - 30,08 | 300,85k | -14,19% |
| 2026-05-04 | Dr. James Woodruff LillieChief Scientific Officer | -51,71k | 1,47M | Automatic Disposition | 27,50 - 30,08 | 49,34k | -51,17% |
| 2026-05-04 | Mr. Vishwas SetiaCFO | -36,37k | 1,02M | Automatic Disposition | 27,36 - 30,12 | 356,26k | -9,26% |
| 2026-05-04 | Dr. Erin Pennock FoffChief Medical Officer | -50,28k | 1,43M | Automatic Disposition | 27,50 - 30,08 | 350,50k | -12,55% |
| 2026-04-27 | Mr. Jonathan GillisChief Administrative & Accounting Officer | -69,84k | 2,09M | Automatic Disposition | 28,94 - 30,83 | 0,00 | -100,00% |
| 2026-04-27 | Dr. Anatol KreitzerChief Discovery Officer | -45,42k | 1,35M | Automatic Disposition | 28,96 - 30,50 | 211,19k | -17,70% |
| 2026-04-15 | Mr. Vishwas SetiaCFO | -2,92k | 78,57k | Verkauf | 26,87 - 27,49 | 36,44k | -7,42% |
| 2026-04-15 | Dr. James Woodruff LillieChief Scientific Officer | -4,51k | 122,57k | Verkauf | 26,82 - 27,49 | 101,05k | -4,28% |
| 2026-04-15 | Dr. Christopher A. KroegerFounder, President, CEO & Director | -19,19k | 521,15k | Verkauf | 26,93 - 27,49 | 350,59k | -5,19% |
| 2026-04-15 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -8,59k | 231,15k | Automatic Disposition | 26,90 | 149,40k | -5,44% |
| 2026-04-15 | Mr. Kristopher L. HansonGeneral Counsel & Secretary | -1,83k | 49,13k | Verkauf | 26,80 - 27,49 | 27,79k | -6,17% |
| 2026-04-15 | Mr. Jonathan GillisChief Administrative & Accounting Officer | -3,59k | 95,53k | Verkauf | 26,61 | 69,30k | -4,93% |
| 2026-04-15 | Dr. Erin Pennock FoffChief Medical Officer | -3,21k | 86,86k | Verkauf | 26,84 - 27,49 | 400,78k | -0,80% |
| 2026-04-15 | Dr. Anatol KreitzerChief Discovery Officer | -3,32k | 88,24k | Verkauf | 26,61 | 66,08k | -4,78% |
| 2026-02-20 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -14,20k | 260,40k | Verkauf | 18,03 - 19,06 | 141,54k | -9,11% |
| 2026-02-18 | Mr. George A. PavlovIndependent Chairman of the Board | 25,00k | 441,17k | Kauf | 17,48 - 17,86 | 25,00k | - |
| 2026-02-13 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -12,12k | 220,63k | Verkauf | 18,21 | 155,74k | -7,22% |
| 2026-02-10 | Dr. Timothy J. GarnettIndependent Director | 14,12k | 252,68k | Kauf | 17,89 | 40,55k | 53,45% |
| 2026-02-10 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -6,86k | 124,33k | Verkauf | 18,00 - 18,12 | 167,86k | -3,93% |
| 2026-02-02 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -7,04k | 126,86k | Verkauf | 18,00 - 18,02 | 174,72k | -3,87% |
| 2026-01-28 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | -34,40k | 635,86k | Verkauf | 18,11 - 19,05 | 181,76k | -15,91% |
| 2026-01-27 | Dr. Erin Pennock FoffChief Medical Officer | -44,62k | 802,20k | Sale to Issuer | 17,98 | 390,48k | -10,25% |
| 2026-01-27 | Mr. Jonathan GillisChief Administrative & Accounting Officer | -22,05k | 396,46k | Sale to Issuer | 17,98 | 65,79k | -25,10% |
| 2026-01-27 | Dr. Christopher A. KroegerFounder, President, CEO & Director | -204,15k | 3,67M | Sale to Issuer | 17,98 | 301,95k | -40,34% |
| 2026-01-27 | Mr. Kristopher L. HansonGeneral Counsel & Secretary | -26,01k | 467,61k | Sale to Issuer | 17,98 | 23,90k | -52,11% |
| 2026-01-27 | Dr. James Woodruff LillieChief Scientific Officer | -45,06k | 810,09k | Sale to Issuer | 17,98 | 94,40k | -32,31% |
| 2026-01-27 | Mr. Vishwas SetiaCFO | -33,38k | 600,21k | Sale to Issuer | 17,98 | 31,28k | -51,63% |
| 2026-01-27 | Dr. Anatol KreitzerChief Discovery Officer | -42,10k | 756,94k | Sale to Issuer | 17,98 | 52,28k | -44,61% |
| 2025-10-28 | Novo Holdings A/SUnternehmen | 2,73M | 0,00 | Derivative Exercise and Retained Stock | - | - | - |
| 2025-10-28 | Novo Holdings A/SUnternehmen | 952,94k | 16,20M | Kauf | 17,00 | - | - |
| 2025-10-28 | Catalyst4, IncUnternehmen | 14,26M | 0,00 | Derivative Exercise and Retained Stock | - | 19,70M | 262,01% |
| 2025-10-28 | Catalyst4, IncUnternehmen | 5,44M | 92,50M | Kauf | 17,00 | 19,70M | 38,17% |
| 2025-10-28 | Dr. Christopher A. KroegerFounder, President, CEO & Director | 3,90k | 0,00 | Derivative Exercise and Retained Stock | - | 285,44k | 1,38% |
| 2025-10-28 | Dr. Robert C. MalenkaCo-Founder, Member of Scientific Advisory Board & Director | 3,90k | 0,00 | Derivative Exercise and Retained Stock | - | 31,67k | 14,02% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
